文献速递男科与性医学前列腺增生与排尿功能障碍

有或无外照射放疗史男性远端球部双袖套人工尿道括约肌植入的功能结局:一项前瞻性数据库分析

Functional outcomes of artificial urinary sphincter implantation with distal bulbar double cuff in men with and without a history of external beam radiotherapy: an analysis of a prospective database.
PubMed 文献 · BJU Int · 2019-08-26

该研究基于2009至2015年前瞻性数据库,分析150例接受远端球部双袖套人工尿道括约肌(DC-AUS)植入的男性压力性尿失禁患者,其中73例(48.7%)有外照射放疗(RT)史。结果显示总体社交控尿率94.8%、客观控尿率84.3%,RT与非RT患者在控尿率、并发症率及装置取出率上均无统计学显著差异。作者认为DC-AUS对有RT史的男性压力性尿失禁是有效且安全的治疗策略。

要点

  • 150例DC-AUS植入患者中73例(48.7%)有放疗史,中位随访24个月。
  • 总体社交控尿率94.8%、客观控尿率84.3%;RT与非RT组控尿率无统计学显著差异。
  • RT与非RT组感染、侵蚀、机械故障及装置取出率均无统计学显著差异。

核心结论

  • 作者认为,来自大型机构系列的数据表明DC-AUS植入对于有放疗史的压力性尿失禁男性是有效且安全的治疗策略。

研究设计与样本

  • 前瞻性收集2009至2015年所有接受远端球部双袖套人工尿道括约肌(DC-AUS)植入患者的数据。
  • 共150例男性(中位年龄70岁,四分位距66-74岁)纳入分析,其中73例(48.7%)有外照射放疗史。
  • DC植入指征基于尿道风险因素,包括放疗及既往近端球部尿道干预(尿道狭窄或压力性尿失禁的内镜或开放手术)。
  • 按标准化方案植入,术后6周激活AUS;随访包括尿垫试验、尿流率、残余尿测定、影像学及标准化问卷。
  • 采用Kaplan-Meier曲线和log-rank检验估计无取出生存率,并行Firth惩罚Cox回归分析取出的风险比。

主要发现

  • 中位随访24个月(四分位距7.25-36个月)。
  • 基线临床特征仅在既往开放压力性尿失禁手术方面存在差异(P=0.016)。
  • 全部患者社交控尿率94.8%、客观控尿率84.3%。
  • RT组与非RT组社交控尿率100% vs 90.2%(P=0.194),客观控尿率87% vs 82%(P=0.877),均无统计学显著差异。
  • RT组与非RT组并发症率无显著差异:感染(P=0.09)、侵蚀(P=0.31)、机械故障(P=0.14);Kaplan-Meier分析示取出率26.0% vs 20.8%,无取出生存率及AUS耐久性无显著差异(log-rank P=0.219)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To analyse functional outcomes and complication rates of artificial urinary sphincter (AUS) implantation with a distal bulbar double cuff (DC) for the treatment of stress urinary incontinence (SUI) in men with and without a history of external beam radiotherapy (RT). PATIENTS AND METHODS: Data of all patients undergoing AUS implantation with a distal bulbar DC (DC-AUS) were collected prospectively from 2009 to 2015. Indications for DC implantation were based on urethral risk factors in terms of RT and previous proximal bulbar urethral interventions including, endoscopic or open surgery for urethral stricture or SUI. Implantation was carried out to a standardised protocol. Activation of the AUS was performed 6 weeks after implantation. Further follow-up (FU) included pad test, uroflowmetry, post-void residual urine measurements, radiography, and a standardised questionnaire. Continence and complication rates were compared between patients with a history of RT and non-RT patients. Explantation-free survival was estimated using Kaplan-Meier curves and the log-rank test. Firth's penalized Cox-regression analyses were performed to analyse proportional hazard ratios for explantation. RESULTS: In all, 150 men (median age 70 years, interquartile range [IQR] 66-74) after DC-AUS implantation were available for analysis. Overall, 73 men (48.7%) had a history of RT. The median (IQR) FU was 24 (7.25-36) months. Baseline clinical characteristics only differed regarding previous open SUI surgery (P = 0.016). Social and objective continence was achieved in 94.8% and 84.3% of all patients treated by implantation of a DC-AUS, respectively. Between the RT and non-RT patients there were no statistically significant differences in continence rates [social continence: 100% vs 90.2% (P = 0.194); objective continence: 87% vs 82% (P = 0.877)]. For complications rates there were no significant differences between RT and non-RT patients after DC-AUS implantation [infection (P = 0.09), erosion (P = 0.31), mechanical failures (P = 0.14)]. According to Kaplan-Meier analysis explantation rates in patients with a history of RT (26.0%) vs non-RT patients (20.8%), estimated explantation-free survival, and AUS durability, did not differ significantly (log-rank P = 0.219). CONCLUSION: Our data from a large institutional series indicate DC-AUS implantation to be an effective and safe treatment strategy in men with SUI and a history of RT.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Maurer V, Marks P, Dahlem R, et al. Functional outcomes of artificial urinary sphincter implantation with distal bulbar double cuff in men with and without a history of external beam radiotherapy: an analysis of a prospective database. BJU Int. 2019. PMID: 31351030. doi:10.1111/bju.14882

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。